Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Nivestim™ in Treatment of Malignant Diseases

This study has been completed.
Information provided by (Responsible Party):
Hospira, Inc. Identifier:
First received: June 7, 2012
Last updated: July 23, 2015
Last verified: July 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2013
  Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)